Generated Narrative: NamingSystem CCDD Summary Defining URL http://terminology.hl7.org/NamingSystem/CCDD Version 1.1.0 Name CCDD Title Canadian Clinical Drug Data Set Status active Definition The Canadian Clinical Drug Data Set provides codes for identification and a consistent approach to naming of medications and some medical devices in Canada. It has been designed and developed to reflect current clinical practice and safety advice and is freely available for use in digital health solutions and design applications. CCDD is available in English and Canadian French. To request content changes, send an email to clinicaldrug@infoway-inforoute.ca. Canada Health Infoway has developed a FHIR representation of CCDD, which can be viewed at: https://ontoserver.csiro.au/shrimp/launch.html?iss=https://terminologystandardsservice.ca/fhir The CCDD FHIR representation contains supplemental property codes, as defined in the Health Canada Drug Product Database (DPD), managed by Health Canada, as follows: Anatomical Therapeutical Chemical (ATC): The purpose of the ATC classification system is to be used as a tool for drug utilization research to improve the quality of drug use. Biosimilar: Identifies biosimilar products. Pediatric: Identifies pediatric products. Schedule: Each drug is assigned one or more schedules according to the Food and Drug Regulations and the Controlled Drugs and Substances Act. Further information on the supplemental properties may be obtained by reviewing the information at https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html or by emailing pharma_drug_enquiries-renseignements_medicaments_pharma@hc-sc.gc.ca Publisher Health Canada Identifiers Type Value Preferred Period Comment OID 2.16.840.1.113883.2.20.6.1 true URI http://terminology.hl7.org/CodeSystem/hc-CCDD true 2021-04-14 --> (ongoing) Official canonical URL going forward. URI https://fhir.infoway-inforoute.ca/CodeSystem/canadianclinicaldrugdataset false Maintained for backward compatibility.
Health Canada; Health Products and Food Branch; Daniel Buijs
Health Canada; Health Products and Food Branch
The Canadian Clinical Drug Data Set provides codes for identification and a consistent approach to naming of medications and some medical devices in Canada. It has been designed and developed to reflect current clinical practice and safety advice and is freely available for use in digital health solutions and design applications. CCDD is available in English and Canadian French. To request content changes, send an email to [clinicaldrug@infoway-inforoute.ca](mailto:clinicaldrug@infoway-inforoute.ca). Canada Health Infoway has developed a FHIR representation of CCDD, which can be viewed at: [https://ontoserver.csiro.au/shrimp/launch.html?iss=https://terminologystandardsservice.ca/fhir](https://ontoserver.csiro.au/shrimp/launch.html?iss=https://terminologystandardsservice.ca/fhir) The CCDD FHIR representation contains supplemental property codes, as defined in the Health Canada Drug Product Database (DPD), managed by Health Canada, as follows: - Anatomical Therapeutical Chemical (ATC): The purpose of the ATC classification system is to be used as a tool for drug utilization research to improve the quality of drug use. - Biosimilar: Identifies biosimilar products. - Pediatric: Identifies pediatric products. - Schedule: Each drug is assigned one or more schedules according to the Food and Drug Regulations and the Controlled Drugs and Substances Act. Further information on the supplemental properties may be obtained by reviewing the information at [https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html](https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html) or by emailing [pharma_drug_enquiries-renseignements_medicaments_pharma@hc-sc.gc.ca](mailto:pharma_drug_enquiries-renseignements_medicaments_pharma@hc-sc.gc.ca)